Coherus Oncology, Inc. Current Assets
Coherus Oncology, Inc. (CHRS) had Current Assets of $133.79 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-05
- 2026-06-30: Assets, Current $133.79M.
- 2026-03-31: Assets, Current $206.03M.
- 2025-12-31: Assets, Current $206.71M.
- 2025-09-30: Assets, Current $460.95M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $133.79M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $206.03M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $206.71M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $460.95M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $380.20M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $310.18M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $341.58M 10-K · filed 2026-03-09 |
| 2024-09-30 | $369.02M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $557.93M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $627.48M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $475.63M 8-K · filed 2025-11-13 |
| 2023-09-30 | $444.37M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $385.48M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $315.93M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $381.23M 10-K · filed 2024-03-15 |
| 2022-09-30 | $448.27M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $446.78M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $512.44M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $602.32M 10-K · filed 2023-03-06 |
| 2021-09-30 | $673.04M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $660.01M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $617.26M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $767.48M 10-K · filed 2022-02-23 |
| 2020-09-30 | $726.92M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $675.86M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $395.18M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $343.01M 10-K · filed 2021-02-25 |
| 2019-09-30 | $276.38M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $205.63M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $159.16M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $84.43M 10-K · filed 2020-02-27 |
| 2018-09-30 | $130.31M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $172.78M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $112.24M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $145.48M 10-K · filed 2019-02-28 |
| 2017-09-30 | $171.60M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $153.34M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $208.26M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $161.49M 10-K · filed 2018-03-08 |
| 2016-09-30 | $177.32M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $236.83M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $211.58M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $197.39M 10-K · filed 2017-03-14 |
| 2015-09-30 | $189.30M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $239.59M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $143.90M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $179.14M 10-K · filed 2016-02-29 |
| 2014-09-30 | $118.88M 10-Q · filed 2014-12-15 |
| 2013-12-31 | $45.68M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |